Secures FDA Label Update for Alzheimer’s Disease Treatment

finance.yahoo.com/news/eli-lilly-lly-secures-fda-131024181.html

In This Article:
Eli Lilly and Company (NYSE:LLY) is one of Goldman Sachs’ top healthcare stock picks. On July 9, the company confirmed the approval by the US Food and Drug Administration of a label update for its once-monthly amyloid-targeting therapy for adults with early symptomatic…

This story appeared on finance.yahoo.com, 2025-07-15 13:10:24.
The Entire Business World on a Single Page. Free to Use →